SELGANTOLIMOD | SELGANTOLIMOD : Agonist of TLR8
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (3 reviews)
Control Compounds

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
TLR8
  • EC50:220 nM
Agonist
up to 1 uM

Selectivity

In Cell Selectivity Assessment
Potency Assay Off-Target:
The broader selectivity profile of (R)-7 toward immune receptors was assessed in reporter gene assay ...

Potency
Cellular
In Vitro

TLR8

Mode of Action: Agonist

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/acs.jmedchem.0c00100

In Vivo Validations

Rat
Dose: 1 mg/Kg
Route of delivery: Intravenous
Plasma half life: 1.45 h
Systemic clearance: 1.8 L/h/Kg
Volume of Distribution at Steady-State: 1.1 L/Kg

DOI Reference: 10.1021/acs.jmedchem.0c00100

Dose: 5 mg/Kg
Route of delivery: Oral
Cmax: 517 ± 224 nM
Area Under the Curve:: 827 ± 540 nM*h
Bioavailability: 8.8 ± 5.7%

DOI Reference: 10.1021/acs.jmedchem.0c00100

Dog
Dose: 0.25 mg/Kg
Route of delivery: Intravenous
Plasma half life: 1.32 h
Systemic clearance: 1.2 L/h/Kg
Volume of Distribution at Steady-State: 1.01 L/Kg

DOI Reference: 10.1021/acs.jmedchem.0c00100

Dose: 0.5 mg/Kg
Route of delivery: Oral
Cmax: 9.7 ± 7.7 nM
Area Under the Curve:: 11.8 ± 7.3 nM*h
Bioavailability: 0.8 ± 0.5%

DOI Reference: 10.1021/acs.jmedchem.0c00100

Monkey (Cynomolgus)
Dose: 0.1 mg/Kg
Route of delivery: Intravenous
Plasma half life: 0.67 h
Systemic clearance: 6.2 L/h/Kg
Volume of Distribution at Steady-State: 2.1 L/Kg

DOI Reference: 10.1021/acs.jmedchem.0c00100

Dose: 3 mg/Kg
Route of delivery: Oral
Cmax: 1.2 ± 0.5 nM
Area Under the Curve:: 4.7 ± 4.2 nM*h
Bioavailability: 0.3 ± 0.2%

DOI Reference: 10.1021/acs.jmedchem.0c00100

Woodchuck
Dose: 3 mg/kg once weekly for 8 weeks
Route of delivery: Oral
Target engagement assay: Plasma GS-9688 levels were approximately dose-proportional after a single oral dose of 0.3, 1, 3, and 10 mg/kg GS-9688.

DOI Reference: 10.1002/hep.31255

Chemical Information

Molecular Formula C14H20FN5O
SMILEs CCCC[C@](C)(CO)Nc1nc(N)nc2cc(F)cnc12
InChI InChI=1S/C14H20FN5O/c1-3-4-5-14(2,8-21)20-12-11-10(18-13(16)19-12)6-9(15)7-17-11/h6-7,21H,3-5,8H2,1-2H3,(H3,16,18,19,20)/t14-/m1/s1
Molecular weight 293.17 Da
AlogP 2.0991999999999997
HBond acceptors 6
HBond donors 4
Atoms 41

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


(on 18 Oct 2022)
Cellular Use Rating
In Model Organisms
Although there is no direct demonstration of in-cell target engagement and PD biomarkers are quite distal (cytokine and reporter gene endpoints), the lack of activity across a range of related receptors...
(on 20 Oct 2022)
In Model Organisms
Extensive validation supports (R)-7 as a probe with excellent selectivity for TRL8 among the TRL family. Although biophysical characterization is limited, this probe has been well characterized in cells...
(on 14 Oct 2025)
Cellular Use Rating
In Model Organisms
The binding mechanism is still unclear as no co-crystal structure or relevant experimental assay has been released.
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria